🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral GLP-1 for elderly patients — swallowing and compliance advantages Page 7

Oral GLP-1 for elderly patients — swallowing and compliance advantages

GraceAZ_72 Sat, May 16, 2026 at 5:39 PM 31 replies 967 viewsPage 7 of 7
JessicaH_TX
Senior Member
4,123
13,456
Dec 2023
Houston, TX
May 28, 2026 at 6:32 AM#31
GraceAZ_72 said:
For the archive: it took about six weeks rather than the two I expected, and the difference between those two numbers was the whole of my problem.

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

Happy to go further on any of that.

50 23wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 47 others
Reply Quote Save Share Report
maria_elpaso
Member
312
1,456
Sep 2024
El Paso, TX
May 29, 2026 at 1:40 AM#32
GraceAZ_72 said:
For the archive: it took about six weeks rather than the two I expected, and the difference between those two numbers was the whole of my problem.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

1 24RunnerRach
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
May 29, 2026 at 8:47 PM#33
GraceAZ_72 said:
For the archive: it took about six weeks rather than the two I expected, and the difference between those two numbers was the whole of my problem.

Saving this. It is the first explanation that did not require me to already understand it.

Last edited: May 29, 2026 at 10:47 PM
2 0mike.trainer_LA, sarah_nash92
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
May 30, 2026 at 3:54 PM#34

From the other side of the consultation, briefly. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Last edited: May 30, 2026 at 8:54 PM
3 1Dr.PulmRoch, maya_sedona, stefan_berlin
Reply Quote Save Share Report
adam_van
Member
212
890
Nov 2024
Vancouver, CA
May 31, 2026 at 11:00 AM#35
TrialTracker_MD said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Same pattern here, and in the same order. I had assumed I was the exception until I read this.

4 2hyun_seoul, jim_asheville, matt_MKE and 1 other
Reply Quote Save Share Report
1567

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register